Multicomponent Intervention to Reduce Sexual Risk and Substance Use

Sponsor
Hunter College of City University of New York (Other)
Overall Status
Completed
CT.gov ID
NCT01880489
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
143
1
2
53.1
2.7

Study Details

Study Description

Brief Summary

The objective is to expand and refine an intervention for transgender women (TW) into a 7-session individual- and group-based intervention that is scalable for community settings to reduce sexual risk and substance use and to increase stigma-coping and risk-buffering behaviors among TW in NYC. The investigators will pilot test the intervention with 20 TW and subsequently, conduct a randomized controlled trial with 240 TW to compare the intervention to a wait list control condition.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MI + CBST Intervention
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
143 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Multicomponent Intervention to Reduce Sexual Risk and Substance Use
Actual Study Start Date :
Jun 1, 2013
Actual Primary Completion Date :
Nov 2, 2017
Actual Study Completion Date :
Nov 2, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: MI + CBST Intervention

Seven sessions of Motivational Interviewing and Cognitive Behavioral Skills Training

Behavioral: MI + CBST Intervention
The intervention focuses on exploring health goals, creating an action plan, learning about the impact stress, stigma, and substance use can have on health, improving personal growth and social support, and connecting with resources. The first two sessions will be primarily Motivational Interviewing and will explore participants' feelings about their sexual risk, substance use, non-medically monitored hormone and silicone use, and any other issues. Group sessions (Sessions 3-6) will incorporate Cognitive Behavioral Skills Training focusing barriers to physical and mental health. The last session will focus on reviewing progress toward health goals, identifying barriers to change, and generating a plan for connection to ongoing care to reach target health goals.

No Intervention: Wait List Control Condition

Outcome Measures

Primary Outcome Measures

  1. Number of Unprotected Sex Acts in the Past 90 Days [every 4 months over the course of 8 months]

    Decreases from Baseline in the Number of Unprotected Sex Acts in the past 90 days at 4 and 8 months

  2. Number of Days of Drug Use in the Past 90 Days [every 4 months over the course of 8 months]

    Decreases from Baseline in the Number of Days of Drug Use in the past 90 days at 4 and 8 months

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years of age or older

  • Identify as a transgender woman (assigned male at birth and currently identify as female)

  • Report 3 or more acts of unprotected anal or vaginal sex in the past 90 days and at least 1 in the past 30 days

  • Report 5 or more days of illicit drug use in the past 90 days and at least 2 in the past 30

  • Provide contact information

  • Reside in the NYC metropolitan area

  • Able to complete a survey in English (Spanish-language assistance can be provided by bilingual staff)

  • Provide informed consent

Exclusion Criteria:
  • Unstable, serious psychiatric symptoms

  • Current suicidal/homicidal ideation

  • Evidence of gross cognitive impairment

  • Currently enrolled in a drug abuse treatment or enrolled in an HIV risk or drug use intervention study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY New York New York United States 10018

Sponsors and Collaborators

  • Hunter College of City University of New York
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: H. Jonathon Rendina, Ph.D., Hunter College of City University of New York

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
H. Jonathon Rendina, Assistant Professor, Hunter College of City University of New York
ClinicalTrials.gov Identifier:
NCT01880489
Other Study ID Numbers:
  • R01DA034661
  • R01DA034661
First Posted:
Jun 19, 2013
Last Update Posted:
Aug 7, 2018
Last Verified:
Aug 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by H. Jonathon Rendina, Assistant Professor, Hunter College of City University of New York
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 7, 2018